ITMI20020960A1 - Aldeidi lineari poliinsature e loro derivati ad attivita' antiradicalica e antitumorale - Google Patents

Aldeidi lineari poliinsature e loro derivati ad attivita' antiradicalica e antitumorale

Info

Publication number
ITMI20020960A1
ITMI20020960A1 IT2002MI000960A ITMI20020960A ITMI20020960A1 IT MI20020960 A1 ITMI20020960 A1 IT MI20020960A1 IT 2002MI000960 A IT2002MI000960 A IT 2002MI000960A IT MI20020960 A ITMI20020960 A IT MI20020960A IT MI20020960 A1 ITMI20020960 A1 IT MI20020960A1
Authority
IT
Italy
Prior art keywords
derivatives
polyunsature
radical
linear aldehydes
tumoral activities
Prior art date
Application number
IT2002MI000960A
Other languages
English (en)
Inventor
Riccardo Stradi
Aldo Bertelli
Elena Pini
Original Assignee
Univ Degli Studi Milano
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Degli Studi Milano filed Critical Univ Degli Studi Milano
Priority to IT2002MI000960A priority Critical patent/ITMI20020960A1/it
Publication of ITMI20020960A0 publication Critical patent/ITMI20020960A0/it
Priority to EP03749867A priority patent/EP1501774B9/en
Priority to DK03749867T priority patent/DK1501774T3/da
Priority to AU2003232722A priority patent/AU2003232722A1/en
Priority to PT03749867T priority patent/PT1501774E/pt
Priority to PCT/EP2003/004720 priority patent/WO2003095403A1/en
Priority to AT03749867T priority patent/ATE439338T1/de
Priority to ES03749867T priority patent/ES2329890T3/es
Priority to US10/513,450 priority patent/US20050175555A1/en
Priority to DE60328769T priority patent/DE60328769D1/de
Priority to SI200331667T priority patent/SI1501774T1/sl
Publication of ITMI20020960A1 publication Critical patent/ITMI20020960A1/it
Priority to CY20091101096T priority patent/CY1109512T1/el

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/738—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/02—Acyclic alcohols with carbon-to-carbon double bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/20—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms
    • C07C47/21—Unsaturated compounds having —CHO groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/02—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen
    • C07C69/22—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety
    • C07C69/24—Esters of acyclic saturated monocarboxylic acids having the carboxyl group bound to an acyclic carbon atom or to hydrogen having three or more carbon atoms in the acid moiety esterified with monohydroxylic compounds
IT2002MI000960A 2002-05-07 2002-05-07 Aldeidi lineari poliinsature e loro derivati ad attivita' antiradicalica e antitumorale ITMI20020960A1 (it)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IT2002MI000960A ITMI20020960A1 (it) 2002-05-07 2002-05-07 Aldeidi lineari poliinsature e loro derivati ad attivita' antiradicalica e antitumorale
SI200331667T SI1501774T1 (sl) 2002-05-07 2003-05-06 Polinenasiäśeni ravnoveriĺ˝ni aldehidi in njihovi derivati s protiradikalno aktivnostjo
PT03749867T PT1501774E (pt) 2002-05-07 2003-05-06 Aldeídos lineares polinsaturados e seus derivados com actividade anti-radicalar
DK03749867T DK1501774T3 (da) 2002-05-07 2003-05-06 Flerumættede lineære aldehyder og deres derivater med anti-radikalvirkning
AU2003232722A AU2003232722A1 (en) 2002-05-07 2003-05-06 Polyunsaturated linear aldehydes and their derivatives with anti-radical and anti-tumoral activity
EP03749867A EP1501774B9 (en) 2002-05-07 2003-05-06 Polyunsaturated linear aldehydes and their derivatives with anti-radical activity
PCT/EP2003/004720 WO2003095403A1 (en) 2002-05-07 2003-05-06 Polyunsaturated linear aldehydes and their derivatives with anti-radical and anti-tumoral activity
AT03749867T ATE439338T1 (de) 2002-05-07 2003-05-06 Mehrfach ungesättigte, geradkettige aldehyde und deren derivate mit anti-radikalwirkung
ES03749867T ES2329890T3 (es) 2002-05-07 2003-05-06 Aldehidos poliinsaturados lineales y sus derivados con actividad antirradical.
US10/513,450 US20050175555A1 (en) 2002-05-07 2003-05-06 Polyunsaturated linear aldehydes and their derivatives with anti-radical and anti-tumoral activity
DE60328769T DE60328769D1 (de) 2002-05-07 2003-05-06 Mehrfach ungesättigte, geradkettige aldehyde und deren derivate mit anti-radikalwirkung
CY20091101096T CY1109512T1 (el) 2002-05-07 2009-10-21 Πολυακορεστες γραμμικες αλδευδες και τα παραγωγα τους με δραση εναντιον των ελευθερων ριζων

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI000960A ITMI20020960A1 (it) 2002-05-07 2002-05-07 Aldeidi lineari poliinsature e loro derivati ad attivita' antiradicalica e antitumorale

Publications (2)

Publication Number Publication Date
ITMI20020960A0 ITMI20020960A0 (it) 2002-05-07
ITMI20020960A1 true ITMI20020960A1 (it) 2003-11-07

Family

ID=11449841

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2002MI000960A ITMI20020960A1 (it) 2002-05-07 2002-05-07 Aldeidi lineari poliinsature e loro derivati ad attivita' antiradicalica e antitumorale

Country Status (12)

Country Link
US (1) US20050175555A1 (it)
EP (1) EP1501774B9 (it)
AT (1) ATE439338T1 (it)
AU (1) AU2003232722A1 (it)
CY (1) CY1109512T1 (it)
DE (1) DE60328769D1 (it)
DK (1) DK1501774T3 (it)
ES (1) ES2329890T3 (it)
IT (1) ITMI20020960A1 (it)
PT (1) PT1501774E (it)
SI (1) SI1501774T1 (it)
WO (1) WO2003095403A1 (it)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0111872D0 (en) * 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
US7968605B2 (en) * 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
EP2319518A1 (en) * 2002-02-04 2011-05-11 ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. Use of CO-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
US20080026984A1 (en) * 2002-02-04 2008-01-31 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
GB2395432B (en) * 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
US20070207217A1 (en) * 2003-02-03 2007-09-06 Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda Method for treating a mammal by administration of a compound having the ability to release CO
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
GB0605900D0 (en) * 2006-03-23 2006-05-03 Lipigen As Modulators of nuclear receptors
US9078852B2 (en) * 2008-02-29 2015-07-14 The Brigham And Women's Hospital, Inc. Retinaldehyde in the treatment of obesity, diabetes and other conditions
IT1391663B1 (it) * 2008-11-10 2012-01-17 Giuliani Spa Uso di composti atti ad inibire l' attivita' dell'enzima 5alfa-reduttasi e composizioni farmaceutiche e cosmetiche che li contengono
IT1394921B1 (it) * 2008-11-10 2012-07-27 Giuliani Spa Uso di composti come principi attivi per migliorare l'azione di riparazione cellulare dell'epidermide umana, e composizioni farmaceutiche e cosmetiche che li contengono
EP2241543A1 (en) * 2009-04-17 2010-10-20 Giuliani S.p.A. Process for the preparation of 2,4,6-octatriene-1-oic acid and 2,4,6-octatriene-1-ol
IT1401289B1 (it) 2010-04-22 2013-07-18 Giuliani Spa Composti dotati di attivita' antiossidante nei confronti dei radicali liberi, e composizioni farmaceutiche e cosmetiche che li contengono
EP2407163A1 (en) * 2010-07-16 2012-01-18 Giuliani S.p.A. Compounds with a skin pigmenting activity and pharmaceutical or cosmetic compositions containing them
WO2012145520A2 (en) 2011-04-19 2012-10-26 Alfama, Inc. Carbon monoxide releasing molecules and uses thereof
ES2628634T3 (es) 2011-07-21 2017-08-03 Alfama, Inc. Moléculas liberadoras de monóxido de carbono-rutenio y usos de las mismas
CN117229132B (zh) * 2023-11-10 2024-02-20 济南悟通生物科技有限公司 一种反式-2,4-壬二烯醛的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3679792A (en) * 1969-09-05 1972-07-25 Wrigley W M Jun Co Dialdehyde-containing anti-caries chewing gum compositions
DE10200130A1 (de) * 2002-01-04 2003-07-10 Basf Ag Verfahren zur Herstellung von Polyendialdehydmonoacetalen

Also Published As

Publication number Publication date
EP1501774A1 (en) 2005-02-02
ATE439338T1 (de) 2009-08-15
SI1501774T1 (sl) 2009-12-31
EP1501774B1 (en) 2009-08-12
WO2003095403A1 (en) 2003-11-20
EP1501774B9 (en) 2010-02-24
DK1501774T3 (da) 2009-12-14
AU2003232722A1 (en) 2003-11-11
ITMI20020960A0 (it) 2002-05-07
US20050175555A1 (en) 2005-08-11
CY1109512T1 (el) 2014-08-13
ES2329890T3 (es) 2009-12-02
DE60328769D1 (de) 2009-09-24
PT1501774E (pt) 2009-10-15

Similar Documents

Publication Publication Date Title
ITMI20020960A1 (it) Aldeidi lineari poliinsature e loro derivati ad attivita' antiradicalica e antitumorale
WO2007001883A3 (en) Method to reduce oxidative damage and improve mitochondrial efficiency
CR9987A (es) Compuestos de lactama y métodos de uso de los mismos
CL2016002589A1 (es) Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348).
EP3330252A3 (en) Isoprenyl compounds and methods thereof
CY1111121T1 (el) Ετεροαρυλο ενωσεις χρησιμες ως αναστολεις ενζυμων ενεργοποiησης ε1
ECSP088923A (es) Compuestos de triazolopirazina utiles para el tratamiento de enfermedades degenerativas e inflamatorias
MX2008001643A (es) Metodo para conservar la funcion de celulas productoras de insulina.
CY1113166T1 (el) Αναστολεις των ενζυμων ενεργοποιησης ε1
BRPI0606112A2 (pt) 3 - heteroaril - 3 - hidróxi - 2 - amino - propil aminas e compostos relacionados, bem como uso dos mesmos e composição farmacêutica
NO20073574L (no) Triazolsubstituerte aminobenzofenonforbindelser
MX338807B (es) Composicion farmaceutica que comprende un compuesto indol.
MX2010001849A (es) Depsipeptidos ciclicos.
DE60314420D1 (de) Zusammensetzung auf grundlage substituierter 1,3-diphenylprop-2-en-1-on-derivaten, deren herstellung und verwendungen
TW200700358A (en) Organic compounds
HK1119557A1 (en) Anti-inflammatory modalities
MY162923A (en) Compound comprising extracts or fractions of chrysanthemum boreale makino having anti-inflammation activity
SV2006002220A (es) Derivados de alquiliden-tetrahidronaftaleno, procedimiento para su preparacion y su uso como antiinflamatorios ref. p-sv-78.836/cd
DOP2003000621A (es) Inhibidores triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa
WO2004026253A3 (en) Novel lapacho compounds and methods of use thereof
CL2008003602A1 (es) Compuestos derivados de triazolotriazinas y triazolopirazinas sustituidas; composicion farmaceutica; y su uso en el tratamiento y/o profilaxis de trastornos hematologicos.
AR066068A1 (es) Tejido de planta con un contenido alterado de un componente flavonoide; metodo para obtenerlo y su uso
DE602004025586D1 (de) Alpha-aminoamid derivate zur verwendung als anti-inflammatorische wirkstoffe
WO2011103586A3 (en) Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with 7-hydroxystaurosporine
AR082594A1 (es) Docosahexanoato de pantenilo y su uso para el tratamiento y prevencion de enfermedades cardiovasculares